Ticker name:ROIVRoivant Sciences Ltd.
Country: GB-Sector: Healthcare, Industry: Biotechnology
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.
- CEO: Matthew Gline
- IPO: Dec 08, 2020
- Website:roivant.com (open a new tab)
Market Cap 24B
Last close 34.05$
Key metrics
Largest 20 companies In Biotechnology
| # Position | Ticker | Company Name | Market Cap | Last Price | Action |
|---|---|---|---|---|---|
| 1 | VRTX | VERTEX PHARMACEUTICALS INC / MA | 122B | 480.5$ | |
| 2 | REGN | REGENERON PHARMACEUTICALS, INC. | 70B | 672.15$ | |
| 3 | RVMD | Revolution Medicines, Inc. | 38B | 180.39$ | |
| 4 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | 36B | 272.67$ | |
| 5 | ROIV | Roivant Sciences Ltd. | 24B | 34.05$ | |
| 6 | MRNA | Moderna, Inc. | 24B | 59.49$ | |
| 7 | INSM | INSMED Inc | 23B | 107.02$ | |
| 8 | INCY | INCYTE CORP | 23B | 115.65$ | |
| 9 | UTHR | UNITED THERAPEUTICS Corp | 22B | 529.34$ | |
| 10 | NBIX | NEUROCRINE BIOSCIENCES INC | 17B | 173$ | |
| 11 | BBIO | BridgeBio Pharma, Inc. | 16B | 80.76$ | |
| 12 | ASND | Ascendis Pharma A/S | 16B | 251.76$ | |
| 13 | JAZZ | Jazz Pharmaceuticals plc | 15B | 243.47$ | |
| 14 | EXEL | EXELIXIS, INC. | 14B | 55.53$ | |
| 15 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | 12B | 535.69$ | |
| 16 | BMRN | BIOMARIN PHARMACEUTICAL INC | 11B | 59.11$ | |
| 17 | AXSM | Axsome Therapeutics, Inc. | 11B | 221.64$ | |
| 18 | TECH | BIO-TECHNE Corp | 11B | 71.64$ | |
| 19 | SMMT | Summit Therapeutics Inc. | 10B | 13.5$ | |
| 20 | APGE | Apogee Therapeutics, Inc. | 10B | 134.15$ |